Rationale and design of the research project of the South Florida Center for the Reduction of Cancer Health Disparities (SUCCESS): Study protocol for a randomized controlled trial

Trials

Volumn 15, Issue 1, 2014, Pages

  Carrasquillo, Olveen ^a,b   McCann, Sheila ^c   Amofah, Antony ^c   Pierre, Larry ^d   Rodriguez, Brendaly ^a   Alonzo, Yisel ^a   Ilangovan, Kumar ^a   Gonzalez, Martha ^b   Trevil, Dinah ^b   Byrne, Margaret M ^a,b   Koru Sengul, Tulay ^a,b   Kobetz, Erin ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c Health Choice Network   (United States)

^d Center for Haitian Studies   (United States)

Author keywords

Cervical cancer; Community based participatory research; Haitian; Health disparities; Hispanic; Human papilloma virus; Immigrant; Minority; Screening

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CANCER PREVENTION; CANCER SCREENING; CERVICOVAGINAL SELF-SAMPLING DEVICE; CLINICAL PROTOCOL; FEMALE; HAITI; HEALTH AUXILIARY; HEALTH DISPARITY; HEALTH EDUCATION; HISPANIC; HUMAN; IMMIGRANT; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PATIENT CARE; PATIENT EDUCATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF REPORT; STRUCTURED INTERVIEW; UTERINE CERVIX CANCER; WART VIRUS; HEALTH BELIEF; HEALTH CARE ACCESS; HEALTH LITERACY; KNOWLEDGE; PARTICIPATORY RESEARCH; AGED; CONTROLLED STUDY; HEALTH CARE DISPARITY; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; PAPILLOMAVIRIDAE; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; UTERINE CERVICAL NEOPLASMS;

ADULT; AGED; CLINICAL PROTOCOLS; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PAPILLOMAVIRIDAE; RESEARCH DESIGN; SAMPLE SIZE; UTERINE CERVICAL NEOPLASMS;

EID: 84904534998     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-15-299     Document Type: Article

References (30)

1. U.S. Cancer Statistics Working Group United States Cancer Statistics: 1999-2010 Incidence and Mortality Web-Based Report 2013, Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, [http://www.cdc.gov/uscs], U.S. Cancer Statistics Working Group.
2. Percentage of Advanced Stage Percentage of Advanced Stage Cancer at Diagnosis by Sex and Race. Florida Cancer Data System Annual Cancer Report (Table #7) 2010, Miami: Bureau of Epidemiology, Florida Department of Health, [https://fcds.med.miami.edu/inc/annual/2010/Table_No_T7_(2010).pdf], Percentage of Advanced Stage.
3. Moyer VA, . on behalf of the U.S. Preventive Services Task Force Screening for cervical cancer: U.S. Preventive services task force recommendation statement. Ann Int Med 2012, 156:880-891. on behalf of the U.S. Preventive Services Task Force.
4. Cancer Screening - United States 2010, MMWR 61 No. 3; 2012.
5. Echeverria SE, Carrasquillo O. The roles of citizenship status, acculturation, and health insurance in breast and cervical cancer screening among immigrant women. Med Care 2006, 44(8):788-792.
6. Kobetz E, Menard J, Barton B, Pierre L, Diem J, Auguste PD. Patne en Aksyon: addressing cancer disparities in Little Haiti through research and social action. Am J Public Health 2009, 99:1163-1165.
7. Paskett ED, Tatum CM, D'Agostino R, Rushing J, Velez R, Michielutte R, Dignan M. Community-based interventions to improve breast and cervical cancer screening: results of the Forsyth County Cancer Screening (FoCaS) Project. Cancer Epidemiol Biomarkers Prev 1999, 8:453-459.
8. Fernandez ME, Gonzales A, Tortolero-Luna G, Williams J, Saavedra-Embesi M, Chan W, Vernon SW. Effectiveness of Cultivando la Salud: a breast and cervical cancer screening promotion program for low-income Hispanic women. Am J Public Health 2009, 99(5):936-943.
9. Sabatino SA, Lawrence B, Elder R, Mercer SL, Wilson KM, DeVinney B, Melillo S, Carvalho M, Taplin S, Bastani R, Rimer BK, Vernon SW, Melvin CL, Taylor V, Fernandez M, Glanz K. Community preventive services task force. Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. Am J Prev Med 2012, 43:765-786.
10. Kitchener HC, Gilham C, Sargent A, Bailey A, Albrow R, Roberts C, Desai M, Mather J, Turner A, Moss S, Peto J. A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial. Eur J Cancer 2011, 47:864-871.
11. Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Johansson B, Forslund O, Hansson BG, Rylander E, Dillner J. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 2007, 357:1589-1597.
12. Food and Drug Administration Brief Summary of the Microbiology Devices Panel Meeting: March 12, 2014 Washington DC: US Department of Health and Human Services, [http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/MicrobiologyDevicesPanel/UCM389192.pdf], Food and Drug Administration.
13. Arbyn M, Verdoodt F, Snijders PJ, Verhoef VM, Suonio E, Dillner L, Minozzi S, Bellisario C, Banzi R, Zhao FH, Hillemanns P, Anttila A. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol 2014, 15:172-183.
14. Lazcano-Ponce E, Lorincz AT, Torres L, Salmerón J, Cruz A, Rojas R, Hernández P, Hernández M. Specimen self-collection and HPV DNA screening in a pilot study of 100,242 women. Int J Cancer 2014, 1:10-16.
15. Castle PE, Rausa A, Walls T, Gravitt PE, Partridge EE, Olivo V, Niwa S, Morrissey KG, Tucker L, Katki H, Scarinci I. Comparative community outreach to increase cervical cancer screening in the Mississippi Delta. Prev Med 2011, 52:452-455.
16. Barbee L, Kobetz E, Menard J, Cook N, Blanco J, Barton B, Auguste P, McKenzie N. Assessing the acceptability of self-sampling for HPV among Haitian immigrant women: CBPR in action. Cancer Causes Control 2010, 21:421-431.
17. Chin MH, Walters AE, Cook SC, Huang ES. Interventions to reduce racial and ethnic disparities in health care. Med Care Res Rev 2007, 64(5 Suppl):7S-28S.
18. Viswanathan M, Ammerman A, Eng E, Garlehner G, Lohr KN, Griffith D, Rhodes S, Samuel-Hodge C, Maty S, Lux L, Webb L, Sutton SF, Swinson T, Jackman A, Whitener L. Community-Based Participatory Research: Assessing the Evidence. Summary, Evidence Report/Technology Assessment: 2004 Agency for Healthcare Research and Quality Publication No. 04-E022-2.
19. Perez M, Findley SE, Mejia M, Martinez J. The impact of community health worker training and programs in NYC. J Health Care Poor Underserved 2006, 17(1 Suppl):26-43.
20. Kobetz E, Vatalaro K, Moore A, Earp JA. Taking the transtheoretical model into the field: a curriculum for lay health advisors. Health Promot Pract 2005, 6(3):329-337.
21. Trainer's Guide for Cancer Education Trainer's Guide for Cancer Education National Cancer Institute, NIH Publication No. 02-5052 2001, Trainer's Guide for Cancer Education.
22. Cancer Clinical Trials: A Resource Guide for Outreach, Education, and Advocacy 2002, National Cancer Institute.
23. Collaborative Institutional Training Initiative (CITI program) [http://www.citiprogram.org].
24. Zhao C, Yang H. Approved Assays for Detecting HPV DNA - Design, Indications, and Validation 2012, College of American Pathologists, CAP Today.
25. Stiillman MJ, Day SP, Schutzbank TE. A comparative review of laboratory-developed tests utilizing Invader HPV analyte-specific reagents for the detection of high-risk human papillomavirus. J Clin Virology 2009, 45(Suppl 1):S73-S77.
26. Schiffman M, Clifford G, Buonaguro FM. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agents Cancer 2009, 4:8.
27. Munson E, Kroeger L, Balzer S, Amrhein R, Munson KL, Napierala M, Hudspeth R, Dillon PJ. Comparison of commercial hybridization and automated transcription-mediated amplification modalities for detection of high-risk human papillomavirus nucleic acid. J Clin Microbiol 2014, 52:331-334.
28. Kizer N, Peipert JF. Cervical cancer screening: primum Non nocere. Ann Intern Med 2012, 156(12):896-897.
29. Lofters AK, Moineddin R, Hwang SW, Glazier RH. Does social disadvantage affect the validity of self-report for cervical cancer screening?. Int J Wom Health 2013, 5:29-33.
30. McPhee SJ, Nguyen TT, Shema SJ, Nguyen B, Somkin C, Vo P, Pasick R. Validation of recall of breast and cervical cancer screening by women in an ethnically diverse population. Prev Med 2002, 35:463-473.